These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16835273)

  • 1. Deregulation of Cdt1 induces chromosomal damage without rereplication and leads to chromosomal instability.
    Tatsumi Y; Sugimoto N; Yugawa T; Narisawa-Saito M; Kiyono T; Fujita M
    J Cell Sci; 2006 Aug; 119(Pt 15):3128-40. PubMed ID: 16835273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage.
    Bahassi el M; Myer DL; McKenney RJ; Hennigan RF; Stambrook PJ
    Mutat Res; 2006 Apr; 596(1-2):166-76. PubMed ID: 16481012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ATR-mediated S phase checkpoint prevents rereplication in mammalian cells when licensing control is disrupted.
    Liu E; Lee AY; Chiba T; Olson E; Sun P; Wu X
    J Cell Biol; 2007 Nov; 179(4):643-57. PubMed ID: 18025301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ATM-dependent DNA damage signaling pathway.
    Kitagawa R; Kastan MB
    Cold Spring Harb Symp Quant Biol; 2005; 70():99-109. PubMed ID: 16869743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redundant and differential regulation of multiple licensing factors ensures prevention of re-replication in normal human cells.
    Sugimoto N; Yoshida K; Tatsumi Y; Yugawa T; Narisawa-Saito M; Waga S; Kiyono T; Fujita M
    J Cell Sci; 2009 Apr; 122(Pt 8):1184-91. PubMed ID: 19339550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1.
    Denchi EL; de Lange T
    Nature; 2007 Aug; 448(7157):1068-71. PubMed ID: 17687332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DDB1 maintains genome integrity through regulation of Cdt1.
    Lovejoy CA; Lock K; Yenamandra A; Cortez D
    Mol Cell Biol; 2006 Nov; 26(21):7977-90. PubMed ID: 16940174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
    Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
    Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-induced phosphorylation of Chk2 in an ataxia telangiectasia mutated-dependent manner.
    Gibson SL; Bindra RS; Glazer PM
    Cancer Res; 2005 Dec; 65(23):10734-41. PubMed ID: 16322218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATM/ATR and SMAD3 pathways contribute to 3-indole-induced G₁ arrest in cancer cells and xenograft models.
    Huang SM; Lu KT; Wang YC
    Anticancer Res; 2011 Jan; 31(1):203-8. PubMed ID: 21273599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of NEDD8-activating enzyme induces rereplication and apoptosis in human tumor cells consistent with deregulating CDT1 turnover.
    Milhollen MA; Narayanan U; Soucy TA; Veiby PO; Smith PG; Amidon B
    Cancer Res; 2011 Apr; 71(8):3042-51. PubMed ID: 21487042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A p53-dependent checkpoint pathway prevents rereplication.
    Vaziri C; Saxena S; Jeon Y; Lee C; Murata K; Machida Y; Wagle N; Hwang DS; Dutta A
    Mol Cell; 2003 Apr; 11(4):997-1008. PubMed ID: 12718885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.
    Jo U; Murai Y; Chakka S; Chen L; Cheng K; Murai J; Saha LK; Miller Jenkins LM; Pommier Y
    Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33536335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cdt1 and Cdc6 are destabilized by rereplication-induced DNA damage.
    Hall JR; Lee HO; Bunker BD; Dorn ES; Rogers GC; Duronio RJ; Cook JG
    J Biol Chem; 2008 Sep; 283(37):25356-25363. PubMed ID: 18617514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Geminin induces rereplication in the presence of functional p53.
    Melixetian M; Ballabeni A; Masiero L; Gasparini P; Zamponi R; Bartek J; Lukas J; Helin K
    J Cell Biol; 2004 May; 165(4):473-82. PubMed ID: 15159417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of G₂ checkpoint defect on centromeric instability.
    Deng W; Tsao SW; Mak GW; Tsang CM; Ching YP; Guan XY; Huen MS; Cheung AL
    Oncogene; 2011 Mar; 30(11):1281-9. PubMed ID: 21057540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cdt1 revisited: complex and tight regulation during the cell cycle and consequences of deregulation in mammalian cells.
    Fujita M
    Cell Div; 2006 Oct; 1():22. PubMed ID: 17042960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DTL/CDT2 is essential for both CDT1 regulation and the early G2/M checkpoint.
    Sansam CL; Shepard JL; Lai K; Ianari A; Danielian PS; Amsterdam A; Hopkins N; Lees JA
    Genes Dev; 2006 Nov; 20(22):3117-29. PubMed ID: 17085480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Origin licensing and p53 status regulate Cdk2 activity during G(1).
    Nevis KR; Cordeiro-Stone M; Cook JG
    Cell Cycle; 2009 Jun; 8(12):1952-63. PubMed ID: 19440053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cdt1 overexpression drives colorectal carcinogenesis through origin overlicensing and DNA damage.
    Petropoulos M; Champeris Tsaniras S; Nikou S; Maxouri S; Dionellis VS; Kalogeropoulou A; Karamichali A; Ioannidis K; Danalatos IR; Obst M; Naumann R; Delinasios GJ; Gorgoulis VG; Roukos V; Anastassiadis K; Halazonetis TD; Bravou V; Lygerou Z; Taraviras S
    J Pathol; 2023 Jan; 259(1):10-20. PubMed ID: 36210634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.